Physician profile
Arnav Kumar
NPI 1114281672
$35,513.91
in general payments reported to CMS, 2019-2025
38 companies · $3,966 in 2025
The $3,966 reported for 2025 was more than what 80% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,809 · 2020: $150 · 2021: $1,402 · 2022: $19K · 2023: $4,948 · 2024: $3,817 · 2025: $3,966.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,664 · Travel and Lodging: $3,666 · Consulting Fee: $400 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,663.69 |
| Travel and Lodging | $3,666.13 |
| Consulting Fee | $400.00 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17,434.09 | 2022-2025 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| Abbott Laboratories | $6,659.34 | 2022-2025 | Amplatzer Amulet, Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $1,780.46 | 2019-2025 | Avvigo Guidance System, General - Therapies |
| Abiomed | $1,488.46 | 2020-2025 | Impella |
| Inari Medical, INC. | $923.44 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Edwards Lifesciences Corporation | $848.68 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Mitris Resilia Mitral Valve, Sapien 3 Ultra Resilia |
| Cardiovascular Systems INC. | $782.09 | 2021-2023 | Diamondback Coronary |
| Philips North America LLC | $696.65 | 2023 | |
| Acist Medical Systems, INC. | $425.64 | 2019-2022 | |
| Amgen INC. | $417.53 | 2019-2025 | Repatha, Repatha |
| Teleflex LLC | $403.88 | 2021-2025 | Guideliner, Manta, Trapliner |
| Spectrawave, INC | $400.00 | 2023 | Hypervue Imaging System |
| Baylis Medical Company INC | $352.30 | 2019 | |
| Biotronik INC. | $327.15 | 2022 | |
| Shockwave Medical, INC | $315.30 | 2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $305.62 | 2019-2024 | Ffrct |
| Irhythm Technologies, INC. | $209.23 | 2024 | Zio Xt Patch, Zio Monitor, Zio At Patch |
| Penumbra, INC. | $177.47 | 2021 | |
| Chiesi USA, INC. | $173.57 | 2021-2024 | Kengreal, Cleviprex |
| Novartis Pharmaceuticals Corporation | $166.86 | 2020-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $148.09 | 2024-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $138.75 | 2024-2025 | Eliquis, Camzyos |
| Actelion Pharmaceuticals US, INC. | $130.55 | 2024-2025 | Uptravi, Opsumit |
| Merck Sharp & Dohme LLC | $120.11 | 2023-2025 | Verquvo, Capvaxive |
| Novo Nordisk INC | $114.98 | 2019-2025 | Wegovy |
| Sanofi-Aventis U.S. LLC | $110.15 | 2019 | |
| Pfizer INC. | $81.69 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.98 | 2023-2024 | Jardiance |
| W. L. Gore & Associates, INC. | $55.04 | 2025 | Gore Cardioform Septal Occluder |
| Kiniksa Pharmaceuticals International, Plc | $52.35 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $46.67 | 2024 | |
| Kestra Medical Technology Services, INC. | $36.01 | 2025 | Assure Wcd |
| Smith+Nephew, INC. | $24.60 | 2025 | Renasys Touch |
| Astrazeneca Pharmaceuticals Lp | $23.53 | 2024 | Wainua |
| Bayer Healthcare Pharmaceuticals INC. | $21.10 | 2025 | |
| Janssen Pharmaceuticals, INC | $18.79 | 2024 | Xarelto |
| Cvrx, INC. | $18.74 | 2024 | Barostim Neo System |
| Angiodynamics, INC. | $15.02 | 2024 | Angiovac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arnav Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.